Arkolith/Insider Trading/MIRO/Form 4

Ross Jeffrey James

CHIEF EXECUTIVE OFFICER, DirectorMiromatrix Medical Inc. (MIRO) · full profile →Form 4 · filed Jan 18, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 13, 2023Tax withholding(F)4K$3.26$15K365K
Jan 13, 2023Grant(A)50K—$0370K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 13, 2023Grant(A)100K—$0100K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-23-001095) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML